Vanessa Silva Dutra Carvalho

Vanessa Silva Dutra Carvalho

Auto-generated profile, based on publicly available information

Vanessa Silva Dutra Carvalho

Departamento de Microbiologia, Instituto de Ciências Biológicas, Universidade Federal de Minas Gerais, Belo Horizonte, Minas Gerais, Brazil

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2019 in Biotechnology Advances
Verified
Journal Article
Closed access
JCJuan Carlos G. Cortés
Juan Carlos G. Cortés
MCM.-Ángeles Curto
M.-Ángeles Curto
VCVanessa S.D. Carvalho
Vanessa S.D. Carvalho
PPPilar Perez
Pilar Perez
JRJuan C. Ribas
Juan C. Ribas

1 January 2018 in Antimicrobial Agents and Chemotherapy
Verified
Journal Article
Closed access
PDF file
RBRafael Wesley Bastos
Rafael Wesley Bastos
HCHellem Cristina Silva Carneiro
Hellem Cristina Silva Carneiro
LOLorena Vívien Neves Oliveira
Lorena Vívien Neves Oliveira
KRKaren Maia Rocha
Karen Maia Rocha
GFGustavo José Cota Freitas
Gustavo José Cota Freitas
DSDaniel Santos
Daniel Santos
Cryptococcus gattii and Cryptococcus neoformans are environmental fungi that cause cryptococcosis, which is usually treated with amphotericin B and fluconazole. However, therapeutic failure is increasing because of the emergence of resistant strains. Because these species are constantly isolated from vegetal materials and the usage of agrochemicals is growing, we postulate that pesticides could be responsible for the altered susceptibility of these fungi to clinical drugs. Therefore, we evaluated the influence of the pesticide tebuconazole on the susceptibility to clinical drugs, morphophysiology, and virulence of C. gattii and C. neoformans strains. The results showed that tebuconazole exposure caused in vitro cross-resistance (CR) between the agrochemical and clinical azoles (fluconazole, itraconazole, and ravuconazole) but not with amphotericin B. In some strains, CR was observed even after the exposure ceased. Further, tebuconazole exposure changed the morphology, including formation of pseudohyphae in C. neoformans H99, and the surface charge of the cells. Although the virulence of both species previously exposed to tebuconazole was decreased in mice, the tebuconazole-exposed colonies recovered from the lungs were more resistant to azole drugs than the nonexposed cells. This in vivo CR was confirmed when fluconazole was not able to reduce the fungal burden in the lungs of mice. The tolerance to azoles could be due to increased expression of the ERG11 gene in both species and of efflux pump genes ( AFR1 and MDR1 ) in C. neoformans . Our study data support the idea that agrochemical usage can significantly affect human pathogens present in the environment by affecting their resistance to clinical drugs.

23 July 2012 in Mycoses
Verified
Journal Article
Closed access
PDF file
JLJuliana Pereira Lyon
Juliana Pereira Lyon
LMLeonardo Marmo Moreira
Leonardo Marmo Moreira
VCVanessa Silva Dutra de Carvalho
Vanessa Silva Dutra de Carvalho
FSFabio Santos
Fabio Santos
CLCarlos José de Lima
Carlos José de Lima
MRMaria Aparecida de Resende
Maria Aparecida de Resende

1 February 2019 in Phytomedicine
Verified
Journal Article
Closed access
EBEstefanía Butassi
Estefanía Butassi
LSLaura Andrea Svetaz
Laura Andrea Svetaz
MSMaximiliano A. Sortino
Maximiliano A. Sortino
AQAriel D. Quiroga
Ariel D. Quiroga
VCVanessa S.D. Carvalho
Vanessa S.D. Carvalho
SZSusana Zacchino
Susana Zacchino

9 January 2020 in Medical Mycology
Verified
Journal Article
Closed access
TMThais Furtado Ferreira Magalhães
Thais Furtado Ferreira Magalhães
MCMarliete Carvalho Costa
Marliete Carvalho Costa
RHRodrigo Assunção Holanda
Rodrigo Assunção Holanda
GFGabriela Freitas Ferreira
Gabriela Freitas Ferreira
VCVanessa Silva Dutra Carvalho
Vanessa Silva Dutra Carvalho
DSDaniel Santos
Daniel Santos
Cryptococcosis is a life-threatening fungal infection, and its current treatment is toxic and subject to resistance. Drug repurposing represents an interesting approach to find drugs to reduce the toxicity of antifungals. In this study, we evaluated the combination of N-acetylcysteine (NAC) with amphotericin B (AMB) for the treatment of cryptococcosis. We examined the effects of NAC on fungal morphophysiology and on the macrophage fungicidal activity 3 and 24 hours post inoculation. The therapeutic effects of NAC combination with AMB were investigated in a murine model with daily treatments regimens. NAC alone reduced the oxidative burst generated by AMB in yeast cells, but did not inhibit fungal growth. The combination NAC + AMB decreased capsule size, zeta potential, superoxide dismutase activity and lipid peroxidation. In macrophage assays, NAC + AMB did not influence the phagocytosis, but induced fungal killing with different levels of oxidative bursts when compared to AMB alone: there was an increased reactive oxygen species (ROS) after 3 hours and reduced levels after 24 hours. By contrast, ROS remained elevated when AMB was tested alone, demonstrating that NAC reduced AMB oxidative effects without influencing its antifungal activity. Uninfected mice treated with NAC + AMB had lower concentrations of serum creatinine and glutamate-pyruvate transaminase in comparison to AMB. The combination of NAC + AMB was far better than AMB alone in increasing survival and reducing morbidity in murine-induced cryptococcosis, leading to reduced fungal burden in lungs and brain and also lower concentrations of pro-inflammatory cytokines in the lungs. In conclusion, NAC + AMB may represent an alternative adjuvant for the treatment of cryptococcosis.

20 December 2021 in Pharmaceuticals
Verified
Journal Article
Open access
PDF file
NYNatalia Yagüe
Natalia Yagüe
LGLaura Gómez-Delgado
Laura Gómez-Delgado
MCM. Ángeles Curto
M. Ángeles Curto
VCVanessa S. D. Carvalho
Vanessa S. D. Carvalho
MMM. Belén Moreno
M. Belén Moreno
JCJuan Carlos G. Cortés
Juan Carlos G. Cortés
Fission yeast contains three essential β(1,3)-D-glucan synthases (GSs), Bgs1, Bgs3, and Bgs4, with non-overlapping roles in cell integrity and morphogenesis. Only the bgs4+ mutants pbr1-8 and pbr1-6 exhibit resistance to GS inhibitors, even in the presence of the wild-type (WT) sequences of bgs1+ and bgs3+. Thus, Bgs1 and Bgs3 functions seem to be unaffected by those GS inhibitors. To learn more about echinocandins’ mechanism of action and resistance, cytokinesis progression and cell death were examined by time-lapse fluorescence microscopy in WT and pbr1-8 cells at the start of treatment with sublethal and lethal concentrations of anidulafungin, caspofungin, and micafungin. In WT, sublethal concentrations of the three drugs caused abundant cell death that was either suppressed (anidulafungin and micafungin) or greatly reduced (caspofungin) in pbr1-8 cells. Interestingly, the lethal concentrations induced differential phenotypes depending on the echinocandin used. Anidulafungin and caspofungin were mostly fungistatic, heavily impairing cytokinesis progression in both WT and pbr1-8. As with sublethal concentrations, lethal concentrations of micafungin were primarily fungicidal in WT cells, causing cell lysis without impairing cytokinesis. The lytic phenotype was suppressed again in pbr1-8 cells. Our results suggest that micafungin always exerts its fungicidal effect by solely inhibiting Bgs4. In contrast, lethal concentrations of anidulafungin and caspofungin cause an early cytokinesis arrest, probably by the combined inhibition of several GSs.